Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting

Springer Semin Immunopathol. 2006 Jun;27(4):425-42. doi: 10.1007/s00281-006-0011-x. Epub 2006 May 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / therapy
  • Crohn Disease / immunology
  • Crohn Disease / therapy
  • Humans
  • Immune System Diseases / immunology
  • Immune System Diseases / therapy*
  • Interleukin-12 / antagonists & inhibitors*
  • Interleukin-12 / immunology*
  • Interleukin-15 / immunology
  • Interleukin-17 / immunology
  • Interleukin-18 / immunology
  • Interleukins / antagonists & inhibitors*
  • Interleukins / immunology*
  • Mice
  • Psoriasis / immunology
  • Psoriasis / therapy

Substances

  • Interleukin-15
  • Interleukin-17
  • Interleukin-18
  • Interleukins
  • Interleukin-12